Evercore ISI analyst Vijay Kumar raised the firm’s price target on Intuitive Surgical to $240 from $215 and keeps an In Line rating on the shares, which were also added to the firm’s "Tactical Underperform" list as the firm made a number of changes to its lists as part of its Q1 earnings preview for the MedTech, Life Science Tools and Diagnostics group.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ISRG:
- Intuitive Surgical assumed with a Neutral at UBS
- Intuitive Surgical initiated with a Neutral at UBS
- Evercore says Intuitive Surgical outperformance tied to new system speculation
- Prescription for Profit: 3 “Strong Buy” Healthcare Stocks Analysts Love
- William Blair starts Intuitive Surgical at Outperform on favorable risk/reward
